HomeCompareBHLIF vs MRK

BHLIF vs MRK: Dividend Comparison 2026

BHLIF yields 18181.82% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BHLIF wins by $20382968138483965952.00M in total portfolio value
10 years
BHLIF
BHLIF
● Live price
18181.82%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20382968138483965952.00M
Annual income
$20,164,798,479,641,134,000,000,000.00
Full BHLIF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — BHLIF vs MRK

📍 BHLIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBHLIFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BHLIF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BHLIF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BHLIF
Annual income on $10K today (after 15% tax)
$1,545,454.55/yr
After 10yr DRIP, annual income (after tax)
$17,140,078,707,694,964,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, BHLIF beats the other by $17,140,078,707,694,964,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BHLIF + MRK for your $10,000?

BHLIF: 50%MRK: 50%
100% MRK50/50100% BHLIF
Portfolio after 10yr
$10191484069241982976.00M
Annual income
$10,082,399,239,820,567,000,000,000.00/yr
Blended yield
98.93%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

BHLIF
No analyst data
Altman Z
19.9
Piotroski
4/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BHLIF buys
0
MRK buys
0
No recent congressional trades found for BHLIF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBHLIFMRK
Forward yield18181.82%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$20382968138483965952.00M$56.8K
Annual income after 10y$20,164,798,479,641,134,000,000,000.00$9,798.13
Total dividends collected$20368560651224936448.00M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BHLIF vs MRK ($10,000, DRIP)

YearBHLIF PortfolioBHLIF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$1,828,882$1,818,181.82$11,206$366.19+$1.82MBHLIF
2$312,726,966$310,770,062.56$12,650$502.35+$312.71MBHLIF
3$49,997,862,140$49,663,244,286.24$14,407$694.19+$49997.85MBHLIF
4$7,474,070,205,933$7,420,572,493,443.65$16,585$967.82+$7474070.19MBHLIF
5$1,044,712,232,322,833$1,036,714,977,202,484.10$19,342$1,363.89+$1044712232.30MBHLIF
6$136,547,911,758,351,100$135,430,069,669,765,680.00$22,913$1,947.19+$136547911758.33MBHLIF
7$16,689,313,388,956,088,000$16,543,207,123,374,653,000.00$27,662$2,823.89+$16689313388956.06MBHLIF
8$1,907,542,220,817,720,100,000$1,889,684,655,491,537,200,000.00$34,159$4,173.35+$1907542220817720.25MBHLIF
9$203,896,877,423,206,970,000,000$201,855,807,246,932,000,000,000.00$43,337$6,308.80+$203896877423206976.00MBHLIF
10$20,382,968,138,483,967,000,000,000$20,164,798,479,641,134,000,000,000.00$56,776$9,798.13+$20382968138483965952.00MBHLIF

BHLIF vs MRK: Complete Analysis 2026

BHLIFStock

Bradda Head Lithium Limited, through its subsidiaries, engages in the exploration, development, and mining of lithium mining projects in the United States. It holds 100% interests in Basin East located in central western Arizona, which covers an area of approximately 3.78 square kilometers (km2); Basin West consists of 65 placer mining and 72 lode claims that cover an area of approximately 6.02 km2 situated in central western Arizona; and Wikieup project comprises 120 federal placer mining claims and 225 lode claims, which covers an area of approximately 27.87 km2 located in the Mohave County, Arizona. The company also owns Wilson Salt Flat, a lithium brine project located in Nye County, Nevada; the Eureka lithium brine project covering an area of 11.8km2; and the San Domingo project consists of 68 BLM placer claims, which covers an area of approximately 13.5 km2 located in the Maricopa and Yavapai counties, Arizona. The company was formerly known as Bradda Head Holdings Limited and changed its name to Bradda Head Lithium Limited in September 2021. Bradda Head Lithium Limited is headquartered in Douglas, Isle of Man.

Full BHLIF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this BHLIF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BHLIF vs SCHDBHLIF vs JEPIBHLIF vs OBHLIF vs KOBHLIF vs MAINBHLIF vs JNJBHLIF vs ABBVBHLIF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.